Compound
← Compound
Official website →
CICigna Group
Quotes delayed by up to 15 minutes · informational, not investment advice
Escopo e origem dos dados
- Ativo
- CI
- Moeda das demonstrações
- USD
- Último período anual nesta tabela
- 2025-12-31
- Fonte das demonstrações
- SEC EDGAR
Data de demonstração não é horário de cotação. Dado ausente não é zero. A cobertura varia por ativo e fonte; confira o documento original antes de interpretar um número.
Fontes e metodologiaAbout the company
Cigna Group, established in 1792 and headquartered in Bloomfield, Connecticut, provides insurance products and related services across the United States. The company operates through two primary segments. Its Evernorth division offers a comprehensive array of coordinated and specialized health solutions, including phar…
IndustryMedical - Healthcare Plans
Smart calendar
Organizing upcoming events...
Key metrics
What the market pays
P/E
Price divided by trailing 12-month earnings
11.32×
P/B
Price divided by book value
1.7×
EV/EBITDA
Enterprise value divided by operating cash generation
8.33×
EV/Revenue
Enterprise value divided by revenue
0.35×
What the company earns
ROE
Return on shareholders’ equity
15.2%
ROA
Return on all assets
4.1%
Gross margin
What remains after product costs
11.7%
Operating margin
What remains after operating the business
3.5%
Net margin
How much of each revenue unit becomes profit
2.3%
What it owes
Debt / Equity
Debt for each unit of shareholders’ equity
0.75
Total debt
Sum of borrowings
$31.88B
Cash
Cash available to cover it
$6.3B
Current ratio
Short-term assets divided by short-term liabilities
0.85
Free cash flow
Cash left after investing
-$718M
Risk and growth
Beta
Moves more (>1) or less (<1) than the market
0.32
Revenue growth
Compared with the same period a year earlier
6.6%
Earnings growth
Compared with the same period a year earlier
8.4%
Dividend yield
Trailing 12-month distributions divided by price
2.3%
Market data provider figures for the latest published period. Informational, not investment advice.
What research firms say
Buy 29Hold 10· 39 firms
Published targetsrange 32% from lowest to highest
302.00median 330.00 USD400.00
Recent revisions
JefferiesBuy → Hold
Raymond JamesStrong Buy → Outperform
GuggenheimBuy
Research-firm survey compiled by StreetInsider, Benzinga, Pulse 2.0. This is not Compound analysis or investment advice — Compound does not issue price targets.
Financial statements(USD)
Income statement
| 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|
| Receita | 180.52B | 195.27B | 247.12B | 274.9B |
| Custo dos produtos | -124.83B | -133.8B | -182.51B | -214.99B |
| Despesas com vendas e administrativas | -13.17B | -14.82B | -14.84B | -14.62B |
| Resultado operacional | 8.45B |
News about CI
Motley Fool · 12 days ago
Cigna Group Executive Neville Everett Sells 617 Shares for $175,000
PR Newswire · 13 days ago
The Cigna Group to Host Investor Day on September 30
Follow CI and get agent analysis of what is moving the stock.
Open Compound